Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2000, p. 4361-4366, Vol. 38, No. 12
Department of Pediatrics, Sophia Children's
Hospital, Erasmus University Rotterdam, Rotterdam, The
Netherlands,1 and Department of
Pediatrics, General University Hospital, University of Patras,
School of Medicine, Patras, Greece2
Received 10 July 2000/Returned for modification 28 August
2000/Accepted 25 September 2000
A total of 145 penicillin-nonsusceptible Streptococcus
pneumoniae strains were isolated from young carriers in
Greece and analyzed by antibiotic susceptibility testing, serotyping,
restriction fragment end labeling (RFEL), and penicillin-binding
protein (PBP) genotyping. The serotypes 23A and 23F (54%), 19A and 19F
(25%), 9V (5%), 15A, 15B, and 15C (4%), 6A and 6B (4%), and 21 (4%) were most prevalent in this collection. Fifty-three distinct RFEL
types were identified. Sixteen different RFEL clusters, harboring 2 to
32 strains each, accounted for 82% of all strains. Eight of these
genetic clusters representing 60% of the strains were previously identified in other countries. A predominant lineage of 66 strains (46%) harboring five RFEL types and the serotypes 19F and 23F was
closely related to the pandemic clone Spain23F-1 (genetic
relatedness of Streptococcus pneumoniae
is worldwide a common cause of invasive diseases such as meningitis,
bacteremia, and pneumonia and of upper respiratory tract infections
(1). Pneumococci are often part of the normal nasopharyngeal
flora. Especially young children and elderly people are at risk of
becoming colonized with S. pneumoniae. The colonization risk
increases where crowding occurs, e.g., in day care centers, hospitals,
and nursing homes (23, 30, 31). Although a positive
correlation between colonization with pneumococci and acute otitis
media has been found (12, 36), a relation between
pneumococcal carriage and invasive disease has not yet been proven.
Since the late 1970s and 1980s, antibiotic resistance among pneumococci
has become an emerging problem. Several (multi)drug-resistant clones
have rapidly spread throughout various European countries, North and
Latin America, and Asia (2, 18, 20). Some of these clones
were initially discovered in Spain, where so far the prevalence of
penicillin resistance has reached levels of up to 60%
(4). The most striking example is the spread of the pandemic multidrug-resistant clone 6B from Spain to Iceland in the late 1980s, where until 1988 no drug resistance among S. pneumoniae isolates had been reported. From 1989 to 1992 penicillin resistance rose steeply from 2.3 to 17% (39). In
1993, the resistance level among pneumococcal isolates in Iceland
reached 20%, of which the vast majority was associated with the
serogroups 6, 19, and 23 (25). In 1991, Munoz et al. have
reported the intercontinental spread of a multidrug resistant S. pneumoniae clone of serotype 23F from Spain to the United States
(29). Since then this clone, recently designated pandemic
clone Spain23F-1 (http://www.wits.ac.za/pmen/pmen.htm)
has rapidly spread throughout the United States (27).
Finally, Gasc et al. have described in 1995 the spread of a
penicillin-resistant pneumococcal clone of serotype 9V (pandemic clone
France9V-3) from Spain to France (14).
Throughout the years these clones have been identified in many
countries in different parts of the world (10, 20, 42).
In addition, novel drug-resistant clones have been reported in
France, former Czechoslovakia, Spain, Hungary, Japan, South Africa, the
United States, Chile, England, etc. which tend to spread in a
nationwide manner (6, 13, 16, 17, 19, 35, 37, 45). The risk
for colonization with and spread of antibiotic-resistant strains is
related to younger-age children, occurrence of refractory middle ear
infections, previous antibiotic consumption, and day care attendance
(9, 28, 32).
In Greece, the emergence of antibiotic resistance among pneumococcal
isolates was recognized in the mid 1990s (41). During the
period December 1995 through February 1996, 53% of the pneumococci isolated from healthy carriers attending day care centers appeared to
be resistant to one or more antibiotics, while 29% of these isolates
were penicillin nonsusceptible (41). In a recent study in
which 2,448 infants and toddlers were screened during a 2-year period
(1997 to 1999) for pneumococcal carriage, 16% of the pneumococci demonstrated reduced susceptibility to penicillin
(40; G. Syrogiannopoulos, I. Grivea, G. Katopodis,
and N. Beratis, unpublished data). The aim of the current study was to
identify the molecular epidemiological nature of the
penicillin-nonsusceptible pneumococci isolated in Greece. For this
purpose, molecular analysis was performed on penicillin-nonsusceptible
isolates of the two Greek studies. A total of 145 (multi)resistant
pneumococcal isolates collected from both studies were characterized by
drug susceptibility testing, serotyping, restriction fragment end
labeling (RFEL), and penicillin-binding protein (PBP) genotyping.
Bacteriology.
Penicillin-nonsusceptible S. pneumoniae strains were isolated from the nasopharynx of 338 children attending seven day care centers in the city of Patras,
Southwestern Greece, from December 1995 to February 1996 and from 2,448 children under the age of 2 years visiting health care centers in
Southern and Central Greece from February 1997 to February 1999. Bacteriological diagnosis and susceptibility testing were carried out
at the Laboratory of the Division of Pediatric Infectious Disease of
the University of Patras, Patras, Greece. The bacteriological methods
and serotyping have been described previously (40, 41).
Molecular analysis was performed on 92% of the
penicillin-nonsusceptible isolates, i.e., 34 strains collected from
seven day care centers in Patras and 111 strains collected from 12 different provinces in Central and Southern Greece. In addition, the
Greek isolates were compared with an international collection of
pneumococcal strains representing 193 distinct RFEL types originating
from 16 different countries in America, Europe, Africa, and Asia (M. Sluijter, unpublished observations), in which the international clones
pandemic clone Spain23F-1, pandemic clone
France9V-3, and pandemic clone Spain6B-2 are
present (http://www.wits.ac.za/pmen/pmen.htm).
RFEL analysis.
Typing of the 145 pneumococcal strains by
RFEL analysis was performed as described by van Steenbergen et al.
(44) and as adapted by Hermans et al. (22).
Briefly, purified pneumococcal DNA was digested by the restriction
enzyme EcoRI. The DNA restriction fragments were end labeled
at 72°C with [ BOX PCR fingerprinting.
Typing of the 145 pneumococcal
strains by BOX PCR fingerprinting was performed as described by van
Belkum et al. (43). Briefly, 50 ng of pneumococcal DNA was
amplified by PCR (4 min at 94°C [predenaturation]; 40 cycles of 1 min at 94°C, 1 min at 60°C, and 2 min at 74°C; and 2 min at
74°C [extension]), using primer BOX-A
(5'-ATACTCTTCGAAAATCTCTTCAAAC), which was designed from the
primary structure of the pneumococcal BOX repeat motif. The amplified
products were separated on a 1.5% agarose gel. Gels were stained with
ethidium bromide, and the banding patterns were evaluated visually.
PBP genotyping.
Genetic polymorphism of the penicillin
resistance genes pbp1a, pbp2b, and
pbp2x of the penicillin-nonsusceptible isolates was
investigated by restriction fragment length polymorphism (RFLP) analysis as described previously (20). Briefly, we amplified the genes by PCR. The primers used to amplify the genes
pbp1a, pbp2b, and pbp2x were described
previously (7, 11). The amplification products (5 µl) were
digested by restriction endonuclease HinfI and separated by
agarose gel electrophoresis. Gels were scanned and analyzed by the
Geldoc 2000 system (Bio-Rad). The different PBP genotypes received a
three-number code (e.g., 6-12-34) referring to the RFLP patterns of the
genes pbp1a (6), pbp2b
(11), and pbp2x (33), respectively.
Computer-assisted analysis of the DNA banding patterns.
The
RFEL types were analyzed using the Windows version of the Gelcompar
software version 4 (Applied Maths, Kortrijk, Belgium) after imaging of
the RFEL autoradiograms using the Image master DTS (Pharmacia Biotech,
Uppsala, Sweden). To this end, the DNA fragments in the molecular size
range of 160 to 400 bp were explored. The DNA banding patterns were
normalized using pneumococcus-specific bands present in the RFEL
banding patterns of all strains. Comparison of the banding patterns was
performed by unweighted-pair-group method using arithmetic averages
(34) and using the Jaccard similarity coefficient applied to
peaks (38). Computer-assisted analysis and methods and
algorithms used in this study were carried out according to the
instructions of the manufacturer of Gelcompar. A tolerance of 1.2% in
band position was applied during comparison of the DNA patterns. For
evaluation of the genetic relatedness of the isolates, we used the
following definitions: (i) strains of particular RFEL type are 100%
identical by RFEL analysis; (ii) a RFEL cluster represents a group of
RFEL types that differs in only one band (ca. >95% genetic
relatedness); and (iii) an RFEL lineage represents a group of RFEL
types that differs in <4 bands (ca. >85% genetic relatedness).
Statistical analysis.
For statistical analysis of the
results, we used the Fisher exact test.
A total of 145 penicillin-nonsusceptible pneumococcal
strains were analyzed using serotyping, RFEL, and PBP genotyping.
Serotyping revealed 12 different serotypes, namely, 23F (52%); 23A
(2%); 19F (15%); 19A (10%); 9V (5%); 15A, 15B, and 15C (4%); 6A
(2%); 6B (1%); 21 (4%); 14 (2%); 22 (1%); and 33F (1%)
(40, 41; Syrogiannopoulos et al.,
unpublished). RFEL analysis divided the strains into 53 distinct
RFEL genotypes (Fig. 1). Sixteen genetic clusters were observed in this collection of strains, representing 82%
of the strains and varying in size from 2 to 32 strains. The genetic
relatedness within these clusters was confirmed by BOX PCR
(43) (data not shown). Five of the sixteen clusters
contained two serotypes, while one of the clusters harbored three
different serotypes. We compared the 53 Greek RFEL types with our
international library in which 193 RFEL genotypes of pneumococci from
16 different countries are present (M. Sluijter, unpublished
observations). Six of the clusters representing 60% of the isolates
were previously seen. To analyze the genetic heterogeneity in the
penicillin resistance genes, we performed PBP genotyping. Twenty
distinct PBP genotypes were observed (Table
1). PBP genotype 1-1-1, initially
observed in the pandemic clones 23F and 9V, was most predominantly
observed in this Greek collection; 81 strains representing 13 distinct RFEL types shared this penicillin resistance genotype.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Molecular Epidemiology of Penicillin-Nonsusceptible
Streptococcus pneumoniae among Children in Greece
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
85%). Another lineage, representing 11 strains,
showed close genetic relatedness to the pandemic clone France9V-3. Another lineage of 8 serotype 21 strains was
Greece specific since the RFEL types were not observed in an
international collection of 193 genotypes from 16 different countries.
Characterization of the PBP genes pbp1a, pbp2b,
and pbp2x revealed 20 distinct PBP genotypes of which
PBP type 1-1-1, initially observed in the pandemic clones 23F and 9V,
was predominantly present in 11 RFEL types in this Greek collection of
penicillin-nonsusceptible strains (55%). Sixteen PBP types covering 52 strains (36%) were Greece specific. This study underlines the
strong contribution of penicillin-resistant international clones
to the prevalence and spread of penicillin-nonsusceptible pneumococci
among young children in Greece.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-32P]dATP using DNA polymerase
(Goldstar; Eurogentec, Seraing, Belgium). The radiolabeled fragments
were denatured and separated electrophoretically on a 6%
polyacrylamide sequencing gel containing 8 M urea. Subsequently, the
gel was transferred onto filter paper, vacuum dried (HBI, Saddlebrook,
N.Y.), and exposed for various times at room temperature to ECL
Hyperfilms (Amersham, Bucks, United Kingdom).
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (51K):
[in a new window]
FIG. 1.
Dendrogram of the 53 RFEL types observed among 145 penicillin-nonsusceptible pneumococcal isolates from the nasopharynxes
of Greek children. Molecular sizes of reference bands are indicated in
bases (b). Serotypes, PBP types, RFEL types, bars representing the
number of isolates per RFEL type, clusters and cluster codes are also
shown. NT, nontypeable; D, RFEL types observed at least once in day
care centers. Code "00" refers to untypeable PBP genotypes. Major
serotypes (*) and PBP types (**) within RFEL types are indicated
(for details, see Table 1).
TABLE 1.
Clusters, serotypes, PBP genotypes, and resistance
patterns of the 145 penicillin-resistant pneumococci isolated from the
nasopharynx of young infants in Greece
Clusters IX and X were the most predominantly observed clusters and
consisted of 31 (21%) and 32 strains (22%), respectively (Fig. 1,
Table 1). Both clusters belonged to one predominant lineage of 66 genetically related strains, representing five RFEL types and harboring
the serotypes 23F and 19F. This lineage was closely related to
the pandemic clone Spain23F-1 (genetic relatedness of
90%) which is widely spread all over the world (8, 26,
42). All strains belonging to this lineage showed
resistance to penicillin, chloramphenicol, tetracycline, and
sulfamethoxazole-trimethoprim. In addition, cluster I was also
resistant to erythromycin and clindamycin. Similar to the characteristics of the pandemic clone Spain23F-1, this
lineage invariably demonstrated PBP genotype 1-1-1.
The second lineage representing cluster VII contained 10 strains of serotypes 19F (Fig. 1, Table 1). Cluster VII was observed previously in The Netherlands, Thailand, and Vietnam and showed reduced susceptibility to penicillin, tetracycline, erythromycin and, in most cases, to sulfamethoxazole-trimethoprim. This cluster had another common feature since the genetic analysis of pbp1a by PBP genotyping of the vast majority of the strains was not applicable. Consequently, the PBP genotype of the majority of these strains was 0-3-30. Interestingly, this observation is in agreement with the genetically related strains present in the international data library.
The third lineage representing 12 strains and the clusters III, IV, and V displayed serotype 19A (Fig. 1, Table 1). These strains did not cluster with isolates from the international library and their PBP genotype did not match with any of the PBP genotypes present in the international library. All strains displayed the pbp1a and pbp2b genotype 2-2 that matched with the majority of the penicillin-susceptible pneumococci analyzed so far (Sluijter, unpublished). We observed alterations in the PBP profile of pbp2x, resulting in the genotypes 2-2-75 and 2-2-80. These PBP genotypes invariably corresponded to intermediate resistance to penicillin only.
The fourth lineage represented the clusters XV (two strains) and XVI (nine strains) and harbored the serotypes 9V, 14, and 23A (Fig. 1, Table 1). These clusters corresponded to the pandemic clone France9V-3. All strains showed the PBP genotype 1-1-1 and were invariably resistant to penicillin, sulfamethoxazole-trimethoprim and, in some strains, to chloramphenicol and tetracycline.
The fifth lineage represented the clusters XIII (serotype 21; six strains) and XII (serogroup 23F; two strains) (Fig. 1, Table 1). These clusters were Greece specific since they were not present in the international library. Interestingly, these clusters consisted of strains that were isolated in day care centers only. Cluster XIII was mostly observed in a single day care center, whereas cluster XII was exclusively observed in another day care center (Fig. 1). Cluster XIII displayed PBP type 2-2-76 corresponding to low penicillin resistance. Cluster XII showed a different PBP genotype 2-5-10 with alterations in pbp2b and pbp2x. None of the latter two PBP genotypes were present in the international library.
Both study groups were divided in day care center attendees and non-day care attendees to analyze the contribution of day care center attendance on clustering of pneumococcal strains. We observed that 86% of the strains from the day care center group containing 45 pneumococcal isolates belonged to a cluster. Within the non-day care center group representing 100 pneumococcal isolates, 80% of the strains demonstrated genetic clustering. There was no statistical difference between the two groups. We reanalyzed our data for the largest day care center in Patras, where 21 strains were isolated. We observed that 19 of these 21 strains (90%) clustered within four clusters. Although this percentage demonstrated a higher degree of genetic clustering in children attending day care centers, this difference was statistically not significant.
| |
DISCUSSION |
|---|
|
|
|---|
Serotyping of the penicillin-nonsusceptible isolates revealed that 79% of the Greek strains belonged to serotypes 23F, 23A, 19F, and 19A (40, 41; Syrogiannopoulos et al., unpublished). These data correspond to earlier findings in other European countries and in the Americas in which these serogroups also significantly contributed to the prevalence of penicillin-resistant S. pneumoniae among young carriers (2, 3, 15, 23, 33, 42).
RFEL genotyping of the 145 penicillin-nonsusceptible isolates showed that 82% of the strains matched within genetic clusters. These data suggest that penicillin-resistant pneumococci rapidly spread among children. This is in line with earlier findings by Hermans et al., who demonstrated that the degree of genetic clustering of penicillin-resistant strains in the Netherlands and Thailand is 70 and 74%, respectively, whereas the degree of genetic clustering among Dutch penicillin-susceptible isolates is 32% (21). Similar data have been reported in various other parts of the world, including Europe, the United States, and South America (8, 20, 26, 42).
The present study clearly demonstrates the significant contribution of the pandemic clone Spain23F-1 to the prevalence and spread of penicillin-nonsusceptible pneumococci among young children in Greece. This is in agreement with studies in other countries in which the predominance of this pandemic clone has also been observed (8, 26, 42). In addition, in the latter studies a second predominant clone, the pandemic clone France9V-3, was highly contributive to the penicillin-resistant pneumococcal population. This clone is also present in our Greek collection, but it does not play a predominant role.
Serogroup 19 represented the major serotype among five lineages. The lineages of cluster VI and cluster VII represented mainly multidrug-resistant isolates and were closely related to isolates found in The Netherlands, Thailand, and Vietnam. Multilocus sequence typing (MLST) has demonstrated that cluster VII also matches with multidrug-resistant serotype 19F isolates from Taiwan (B. Spratt, personal communication). The three other lineages, representing clusters I and II, clusters III, IV, and V, and cluster XI, respectively, showed intermediate resistance to penicillin only and displayed new PBP genotypes with alterations in pbp2x only. MLST has demonstrated that clusters III, IV, and V match with a drug-susceptible serotype 19A invasive isolate from the United Kingdom. In general, this study showed a relation between accumulation of alterations in the three PBP genes and level of penicillin resistance; high resistance levels were often associated with changes in the DNA banding patterns of all three PBP genes (18). In addition, there was also a correlation between multidrug resistance and cumulative alterations in all three PBP genes. This phenomenon is in agreement with the previous observations of Hermans et al. and is hypothesized to be the effect of frequent horizontal cotransfer of resistance genes other than PBP genes in pneumococci with high-level penicillin resistance (20).
Only one lineage, representing two RFEL clusters of serotype 21 and 23F, respectively, was found to be Greece specific since they were not present in the international data library. In addition, this lineage was found only in three day care centers. This is strongly suggestive for the dissemination of pneumococcal clones among day care center attendees within and between day care centers. MLST typing has recently demonstrated that this RFEL cluster of serotype 21 matches a drug-susceptible invasive isolate of serotype 21 in the United Kingdom (B. Spratt, personal communication).
In conclusion, our observations demonstrate a high degree of genetic clustering among penicillin-nonsusceptible, often multidrug-resistant pneumococci in young children in Greece, mainly caused by the spread of a restricted number of penicillin-resistant S. pneumoniae clones. Limiting antibiotic prescription and promoting compliance would probably contribute to the control this problem. A better alternative to prevent the spread of multidrug resistant clones in the near future, however, is large-scale vaccination using pneumococcal conjugate vaccines. Although the initial results of the conjugate vaccination trials look promising (5, 24; R. Dagan, N. Givon, P. Yagupsky, et al., Abstr. 38th Intersci. Conf. Antimicrob. Agents Chemother., abstr. G552, 1998), the epidemiological consequences of such strategies need to be monitored in detail.
| |
ACKNOWLEDGMENTS |
|---|
We thank C. P. Elzenaar, A. J. Timmers-Reker, and M. Sluijter for technical support.
This work was sponsored by the Sophia Foundation for Medical Research (grant 268) and the NWO (grant SGO-Inf. 005), The Netherlands.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address for Peter W. M. Hermans: Laboratory of Pediatrics, Rm. Ee1500, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Phone: 31-10-4088224. Fax: 31-10-4089486. E-mail: hermans{at}kgk.fgg.eur.nl. Mailing address for George A. Syrogiannopoulos: Department of Pediatrics, University of Patras, School of Medicine, 26 500 Rion, Patras, Greece. Phone: 61-993948. Fax: 61-994533. E-mail: syrogian{at}med.upatras.gr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anonymous. 1997. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 46:1-24[Medline]. |
| 2. |
Appelbaum, P. C.,
C. Gladkova,
W. Hryniewicz,
B. Kojouharov,
D. Kotulova,
F. Mihalcu,
J. Schindler,
L. Setchanova,
N. Semina,
J. Trupl,
S. Tyski,
P. Urbaskova, and M. R. Jacobs.
1996.
Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe a multicenter study with use of standardized methods.
Clin. Infect. Dis.
23:712-717[Medline].
|
| 3. | Arnold, K. E., R. J. Leggiadro, R. F. Breiman, H. B. Lipman, B. Schwartz, M. A. Appleton, K. O. Cleveland, H. C. Szeto, B. C. Hill, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1996. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J. Pediatr. 128:757-764[CrossRef][Medline]. |
| 4. |
Baquero, F.,
J. A. Garcia-Rodriguez,
J. Garcia de Lomas, and L. Aguilar.
1999.
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.
Antimicrob. Agents Chemother.
43:357-359 |
| 5. | Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J. R. Hansen, L. Elvin, K. M. Ensor, J. Hackell, G. Siber, F. Malinoski, D. Madore, I. Chang, R. Kohberger, W. Watson, R. Austrian, and K. Edwards. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19:187-195[CrossRef][Medline]. |
| 6. | Coffey, T. J., S. Berron, M. Daniels, M. E. Garcia-Leoni, E. Cercenado, E. Bouza, A. Fenoll, and B. G. Spratt. 1996. Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology 142:2747-2757[Abstract]. |
| 7. | Coffey, T. J., C. G. Dowson, M. Daniels, J. Zhou, C. Martin, B. G. Spratt, and J. M. Musser. 1991. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol. 5:2255-2260[Medline]. |
| 8. | Corso, A., E. P. Severina, V. F. Petruk, Y. R. Mauriz, and A. Tomasz. 1998. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb. Drug Resist. 4:325-337[Medline]. |
| 9. | Dagan, R., E. Leibovitz, D. Greenberg, P. Yagupsky, D. M. Fliss, and A. Leiberman. 1998. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr. Infect. Dis. J. 17:880-885[CrossRef][Medline]. |
| 10. | Davies, T., R. V. Goering, M. Lovgren, J. A. Talbot, M. R. Jacobs, and P. C. Appelbaum. 1999. Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diagn. Microbiol. Infect. Dis. 34:7-12[CrossRef][Medline]. |
| 11. | Dowson, C. G., A. Hutchison, and B. G. Spratt. 1989. Extensive re-modelling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae. Mol. Microbiol. 3:95-102[Medline]. |
| 12. | Faden, H., L. Duffy, R. Wasielewski, J. Wolf, D. Krystofik, and Y. Tung. 1997. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J. Infect. Dis. 175:1440-1445[Medline]. |
| 13. | Figueiredo, A. M., R. Austrian, P. Urbaskova, L. A. Teixeira, and A. Tomasz. 1995. Novel penicillin-resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia. Microb. Drug Resist. 1:71-78[Medline]. |
| 14. | Gasc, A. M., P. Geslin, and A. M. Sicard. 1995. Relatedness of penicillin-resistant Streptococcus pneumoniae serogroup 9 strains from France and Spain. Microbiology 141(Pt. 3):623-627[Abstract]. |
| 15. | Ghaffar, F., I. R. Friedland, and G. H. McCracken, Jr. 1999. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr. Infect. Dis J. 18:638-646[CrossRef][Medline]. |
| 16. |
Gherardi, G.,
J. S. Inostrozo,
M. O'Ryan,
V. Prado,
S. Prieto,
C. Arellano,
R. R. Facklam, and B. Beall.
1999.
Genotypic survey of recent beta-lactam-resistant pneumococcal nasopharyngeal isolates from asymptomatic children in Chile.
J. Clin. Microbiol.
37:3725-3730 |
| 17. | Gherardi, G., C. G. Whitney, R. R. Facklam, and B. Beall. 2000. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J. Infect. Dis. 181:216-229[CrossRef][Medline]. |
| 18. |
Hakenbeck, R.
1999.
-Lactam-resistant streptococcus pneumoniae: epidemiology and evolutionary mechanism.
Chemotherapy
45:83-94[CrossRef][Medline].
|
| 19. | Hall, L. M., R. A. Whiley, B. Duke, R. C. George, and A. Efstratiou. 1996. Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J. Clin. Microbiol. 34:853-859[Abstract]. |
| 20. | Hermans, P. W., M. Sluijter, S. Dejsirilert, N. Lemmens, K. Elzenaar, A. van Veen, W. H. Goessens, and R. de Groot. 1997. Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb. Drug Resist. 3:243-251[Medline]. |
| 21. | Hermans, P. W., M. Sluijter, K. Elzenaar, A. van Veen, J. J. Schonkeren, F. M. Nooren, W. J. van Leeuwen, A. J. de Neeling, B. van Klingeren, H. A. Verbrugh, and R. de Groot. 1997. Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J. Infect. Dis. 175:1413-1422[Medline]. |
| 22. | Hermans, P. W., M. Sluijter, T. Hoogenboezem, H. Heersma, A. van Belkum, and R. de Groot. 1995. Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J. Clin. Microbiol. 33:1606-1612[Abstract]. |
| 23. |
Kellner, J. D., and E. L. Ford-Jones.
1999.
Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group.
Arch. Pediatr. Adolesc. Med.
153:495-502 |
| 24. | Korkeila, M., H. Lehtonen, H. Ahman, O. Leroy, J. Eskola, and H. Kayhty. 2000. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine 18:1218-1226[CrossRef][Medline]. |
| 25. | Kristinsson, K. G. 1995. Epidemiology of penicillin resistant pneumococci in Iceland. Microb. Drug Resist. 1:121-125[Medline]. |
| 26. |
Marchese, A.,
M. Ramirez,
G. C. Schito, and A. Tomasz.
1998.
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996.
J. Clin. Microbiol.
36:2944-2949 |
| 27. |
McDougal, L. K.,
R. Facklam,
M. Reeves,
S. Hunter,
J. M. Swenson,
B. C. Hill, and F. C. Tenover.
1992.
Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States.
Antimicrob. Agents Chemother.
36:2176-2184 |
| 28. | Melander, E., S. Molstad, K. Persson, H. B. Hansson, M. Soderstrom, and K. Ekdahl. 1998. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur. J. Clin. Microbiol. Infect. Dis. 17:834-838[CrossRef][Medline]. |
| 29. | Muñoz, R., T. J. Coffey, M. Daniels, C. G. Dawson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, et al. 1991. Intercontinental spread of a multiresistant clone of genotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306[Medline]. |
| 30. |
Nuorti, J. P.,
J. C. Butler,
J. M. Crutcher,
R. Guevara,
D. Welch,
P. Holder, and J. A. Elliott.
1998.
An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.
N. Engl. J. Med.
338:1861-1868 |
| 31. | Principi, N., P. Marchisio, G. C. Schito, and S. Mannelli. 1999. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr. Infect. Dis. J. 18:517-523[CrossRef][Medline]. |
| 32. | Reichler, M. R., A. A. Allphin, R. F. Breiman, J. R. Schreiber, J. E. Arnold, L. K. McDougal, R. R. Facklam, B. Boxerbaum, D. May, R. O. Walton, et al. 1992. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J. Infect. Dis. 166:1346-1353[Medline]. |
| 33. | Reichler, M. R., J. Rakovsky, A. Sobotova, M. Slacikova, B. Hlavacova, B. Hill, L. Krajcikova, P. Tarina, R. R. Facklam, and R. F. Breiman. 1995. Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J. Infect. Dis. 171:1491-1496[Medline]. |
| 34. | Romesburg, H. 1990. Cluster analysis for researchers, p. 9-28. Krieger, Malabar, Fla. |
| 35. |
Sibold, C.,
J. Wang,
J. Henrichsen, and R. Hakenbeck.
1992.
Genetic relationships of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated on different continents.
Infect. Immun.
60:4119-4126 |
| 36. |
Sluijter, M.,
H. Faden,
R. de Groot,
N. Lemmens,
W. H. Goessens,
A. van Belkum, and P. W. Hermans.
1998.
Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life.
J. Clin. Microbiol.
36:2248-2253 |
| 37. | Smith, A. M., and K. P. Klugman. 1997. Three predominant clones identified within penicillin-resistant South African isolates of Streptococcus pneumoniae. Microb. Drug Resist. 3:385-389[Medline]. |
| 38. | Sneath, P. 1973. Numerical taxonomy, p. 131-132. W. H. Freeman, San Francisco, Calif. |
| 39. | Soares, S., K. G. Kristinsson, J. M. Musser, and A. Tomasz. 1993. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis. 168:158-163[Medline]. |
| 40. | Syrogiannopoulos, G., I. Grivea, G. Katopodis, G. P, M. Jacobs, and N. Beratis. 2000. Carriage of antibiotic-resistant Streptococcus pneumoniae in Greek infants and toddlers. Eur. J. Clin. Microbiol. Infect. Dis. 19:288-293[CrossRef][Medline]. |
| 41. | Syrogiannopoulos, G. A., I. N. Grivea, N. G. Beratis, A. E. Spiliopoulou, E. L. Fasola, S. Bajaksouzian, P. C. Appelbaum, and M. R. Jacobs. 1997. Resistance patterns of Streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece. Clin. Infect. Dis. 25:188-194[Medline]. |
| 42. | Tomasz, A., A. Corso, E. P. Severina, G. Echaniz-Aviles, M. C. Brandileone, T. Camou, E. Castaneda, O. Figueroa, A. Rossi, and J. L. Di Fabio. 1998. Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. PAHO/Rockefeller University Workshop. Pan American Health Organization. Microb. Drug Resist. 4:195-207[Medline]. |
| 43. | van Belkum, A., M. Sluijuter, R. de Groot, H. Verbrugh, and P. W. Hermans. 1996. Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains. J. Clin. Microbiol. 34:1176-1179[Abstract]. |
| 44. |
van Steenbergen, T. J.,
S. D. Colloms,
P. W. Hermans,
J. de Graaff, and R. H. Plasterk.
1995.
Genomic DNA fingerprinting by restriction fragment end labeling.
Proc. Natl. Acad. Sci. USA
92:5572-5576 |
| 45. | Yoshida, R., Y. Hirakata, M. Kaku, K. Tomono, S. Maesaki, Y. Yamada, S. Kamihira, M. R. Jacobs, P. C. Appelbaum, and S. Kohno. 1999. Genetic analysis of serotype 23F Streptococcus pneumoniae isolates from several countries by penicillin-binding protein gene fingerprinting and pulsed-field gel electrophoresis. Chemotherapy 45:158-165[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|